Deal Snaps
BioTech startup Nalagenetics raised $12.6 million in Series A round
The Singapore based BioTech startup that builds solutions for interpreting genetic data has secured $12.6 million funds in Series A round.
April 3, 2022
Bayfront's Library
Explore through our library for our market insights, research articles, case studies and more.
PCR